ArticleApplied health economics and health policy2021

Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea.

Siin Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.